Isomorphic Labs Watch posted an update
Isomorphic Labs is reportedly in talks to raise $5bn at a $50bn valuation, according to a report published by Tech Funding News on 5 November. That valuation is the useful new detail: the funding talks were already reported, but this would put a striking price on Alphabet’s AI drug-discovery venture.
Why it mattersThe report describes talks, not a completed round.
Discuss: What would convince you that a $50bn valuation for an AI drug-discovery company is justified?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.